Immunosuppressive therapy in opsoclonus-myoclonus ataxia syndrome associated with paravertebral neuroblastoma

Neurologia (Engl Ed). 2020 Jan-Feb;35(1):54-56. doi: 10.1016/j.nrl.2017.06.006. Epub 2017 Aug 31.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Ataxia / complications
  • Cyclophosphamide / administration & dosage*
  • Dexamethasone / administration & dosage*
  • Female
  • Humans
  • Immunoglobulins / administration & dosage*
  • Immunosuppressive Agents / administration & dosage*
  • Infant
  • Neuroblastoma / surgery*
  • Opsoclonus-Myoclonus Syndrome / therapy*
  • Pediatrics

Substances

  • Anti-Inflammatory Agents
  • Immunoglobulins
  • Immunosuppressive Agents
  • Dexamethasone
  • Cyclophosphamide